Hyalo Technologies
Contact pharmacy ↗ Request an introduction ↗Patient access unconfirmed
Facility identity needs confirmation · Retained for review in the company index.
Peptide and GLP-1 compounding have not been confirmed for this location.
Can this pharmacy serve my state?
Choose your state and service to check shipping and license evidence.
We have not confirmed a shipping policy for this selection. Ask the pharmacy about your medication and destination
We have not matched a state-board record for this state
“Not confirmed” is a gap in our review, not a finding that the pharmacy is unlicensed or cannot ship.
Shipping scope and restrictions
No current enumerated pharmacy shipping or reported-license state list was verified.
Confirm your exact medication and delivery address with the pharmacy. A license record does not confirm that every preparation can be shipped.
License records checked (0)
No matched record date is available. These records are specific to this location. General pharmacy, sterile-compounding and outsourcing permits can have different scopes.
No state-board license record has been matched in this review. This does not mean the pharmacy is unlicensed.
Compare all states
Shipping follows the service selected above. License status is checked separately.
No shipping destination is confirmed in this review.
No state-board license record is matched in this review.
| State | Reported shipping | License status |
|---|
Facility type and oversight
- Facility type
- Not yet confirmedFacility classification awaits confirmation
- Accreditation
- Not yet checkedCurrent scope and status await verification.
Check the facility name, address, scope and expiration with the issuer.
Regulatory history
Earlier PW review recorded “Not yet inspected”. Consult the regulator for the current record.
Compounding specialties
- GLP-1 compounding
- Not confirmed in this review
- Other peptide compounding
- Not confirmed in this review
Peptivik's September 2026 provider-network testing page names Hyalo Technologies as the compounder of tirzepatide lot HT-19 and semaglutide lots HT-14/HT-16. Current GLP-1 preparations are provider-reported, but their manufacturing/dispensing street and facility scope were not resolved against the Somerset corporate identity.
Organization and scale
- Company or brand
- Hyalo Technologies
- Founded
- Not confirmed
- Company-reported scale
- Not confirmed
Where the information came from
Sources and methodology
Services and shipping statements are attributed to their sources; state-board license records are checked separately. Missing information stays unconfirmed. Explore the editorial guide or company research index. Nearby distances use approximate city and ZIP centers from GeoNames under CC BY 4.0. Confirm pickup and current availability directly with the pharmacy.